| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-RCBTB1 (1-120) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
RCBTB1 |
| Gene ID: |
55213 |
| Uniprot ID: |
RCBT1_HUMAN |
| Immunogen Region: |
1-120 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-120 of human RCBTB1 (NP_060661.3). |
| Immunogen Sequence: |
MVDVGKWPIFTLLSPQEIAS IRKACVFGTSASEALYVTDN DEVFVFGLNYSNCLGTGDNQ STLVPKKLEGLCGKKIKSLS YGSGPHVLLSTEDGVVYAWG HNGYSQLGNGTTNQGIAPVQ |
| Tissue Specificity | Ubiquitously expressed. In the retina, present in the nerve fiber layer and to a lesser extent in the inner and outer plexiform layers (at protein level). |
| Function | May be involved in cell cycle regulation by chromatin remodeling. |
| Protein Name | Rcc1 And Btb Domain-Containing Protein 1Chronic Lymphocytic Leukemia Deletion Region Gene 7 ProteinCll Deletion Region Gene 7 ProteinRegulator Of Chromosome Condensation And Btb Domain-Containing Protein 1 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Rcc1 And Btb Domain-Containing Protein 1 antibodyAnti-Chronic Lymphocytic Leukemia Deletion Region Gene 7 Protein antibodyAnti-Cll Deletion Region Gene 7 Protein antibodyAnti-Regulator Of Chromosome Condensation And Btb Domain-Containing Protein 1 antibodyAnti-RCBTB1 antibodyAnti-CLLD7 antibodyAnti-E4.5 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
